Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
International Journal of Technology Assessment in Health Care
|
April 16, 2009
Cost-effectiveness of human papillomavirus vaccination in Belgium: do not forget about cervical cancer screening
Nancy Thiry, Chris De Laet, Frank Hulstaert, et al.
Health Policy (Amsterdam, Netherlands)
|
July 4, 2020
An evaluation of managed entry agreements in Belgium: A system with threats and (high) potential if properly applied
Mattias Neyt, Sophie Gerkens, Lorena San Miguel, et al.
European Journal of Clinical Pharmacology
|
February 28, 2025
Unravelling the implementation of pharmacogenetic testing in Belgium
Jolyce Bourgeois, Elena Costa, Carl Devos, et al.
Vaccine
|
August 19, 2004
An economic evaluation of varicella vaccination in Italian adolescents
Nancy Thiry, Philippe Beutels, Francesco Tancredi, et al.
European Journal of Pediatrics
|
November 9, 2002
The seroepidemiology of primary varicella-zoster virus infection in Flanders (Belgium)
Nancy Thiry, Philippe Beutels, Ziv Shkedy, et al.
International Journal of Technology Assessment in Health Care
|
January 10, 2013
Should chronic hepatitis B be treated as early as possible?
Frank Hulstaert, Christoph Schwierz, Frederik Nevens, et al.
Human Vaccines & Immunotherapeutics
|
February 9, 2018
Economic evaluation of pneumococcal vaccines for adults aged over 50 years in Belgium
Lander Willem, Adriaan Blommaert, Germaine Hanquet, et al.
NPJ Vaccines
|
January 19, 2026
Cost-effectiveness of maternal vaccine and/or monoclonal antibody strategies against respiratory syncytial virus in Belgian infants
Xiao Li, Lander Willem, Dominique Roberfroid, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 5, 2023
Survival in stage IV ovarian cancer with increased use of debulking surgery and bevacizumab
Leen Verleye, Diego Castanares-Zapatero, Carl Devos, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 2, 2023
Belgian observational survival data (incidence years 2004-2017) and expenditure for innovative oncology drugs in twelve cancer indications
Mattias Neyt, Carl Devos, Nancy Thiry, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
International Journal of Technology Assessment in Health Care
|
April 16, 2009
Cost-effectiveness of human papillomavirus vaccination in Belgium: do not forget about cervical cancer screening
Nancy Thiry, Chris De Laet, Frank Hulstaert, et al.
Health Policy (Amsterdam, Netherlands)
|
July 4, 2020
An evaluation of managed entry agreements in Belgium: A system with threats and (high) potential if properly applied
Mattias Neyt, Sophie Gerkens, Lorena San Miguel, et al.
European Journal of Clinical Pharmacology
|
February 28, 2025
Unravelling the implementation of pharmacogenetic testing in Belgium
Jolyce Bourgeois, Elena Costa, Carl Devos, et al.
Vaccine
|
August 19, 2004
An economic evaluation of varicella vaccination in Italian adolescents
Nancy Thiry, Philippe Beutels, Francesco Tancredi, et al.
European Journal of Pediatrics
|
November 9, 2002
The seroepidemiology of primary varicella-zoster virus infection in Flanders (Belgium)
Nancy Thiry, Philippe Beutels, Ziv Shkedy, et al.
International Journal of Technology Assessment in Health Care
|
January 10, 2013
Should chronic hepatitis B be treated as early as possible?
Frank Hulstaert, Christoph Schwierz, Frederik Nevens, et al.
Human Vaccines & Immunotherapeutics
|
February 9, 2018
Economic evaluation of pneumococcal vaccines for adults aged over 50 years in Belgium
Lander Willem, Adriaan Blommaert, Germaine Hanquet, et al.
NPJ Vaccines
|
January 19, 2026
Cost-effectiveness of maternal vaccine and/or monoclonal antibody strategies against respiratory syncytial virus in Belgian infants
Xiao Li, Lander Willem, Dominique Roberfroid, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
January 5, 2023
Survival in stage IV ovarian cancer with increased use of debulking surgery and bevacizumab
Leen Verleye, Diego Castanares-Zapatero, Carl Devos, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 2, 2023
Belgian observational survival data (incidence years 2004-2017) and expenditure for innovative oncology drugs in twelve cancer indications
Mattias Neyt, Carl Devos, Nancy Thiry, et al.
Page
of 3